StockData
GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30

Gelteq Ltd

Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2025
$0.43−0.02 (-3.50%)

Close on Oct 19, 2026

Gelteq Ltd balance sheet

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
30.3%
Operating margin
-3317.7%
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
0.09
Debt to equity
–
Debt to assets
25.4%
Cash to current liabilities
0.2%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

Valuation ratios need the share price and fill in once daily prices are connected.